Liver Pathology Flashcards
What is Hepatocellular Carcinoma (HCC)
- Most common primary liver malignancy
- There is hepatocellular differentiation
- 80% of HCC cases arise in cirrhosis
What are the risk factors of HCC
- Chronic Liver disease leading to cirrhosis
- Infectious; viral hepatitis (HBV or HCV)
- Metabolic: non-alcoholic fatty liver disease (obesity, diabetes), hemochromatosis
- Environmental exposure: aflatoxin, alcohol, steroids, oral contraceptives, tobacco
- Developmental/congenital: abernethy malformation, alagille syndrome
Chronic viral hepatitis is the leading cause of hepatocellular carcinoma worldwide
What is the stepwise process of HCC
1) Low grade dysplastic nodule
2) High grade dysplastic nodule
3) Early hepatocellular carcinoma
4) Progressed hepatocellular carcinoma
This is accompanied by the accumulation of molecular alterations
What are the molecular alterations in HCC
- Telomere shortening
- TERT activation
- Cell cycle checkpoint inhibitor inactivation
TERT promoter mutation is a salient event to hepatocellular carcinoma
How is Telomere Shortening important for the progression of HCC
Telomeres are protective caps at the ends of chromosomes that shorten with each cell division
In HCC, chronic liver damage leads to repeated cell turnover, causing telomeres to shorten faster
Critically short telomeres trigger genomic instability, increasing the risk of mutations and transformation into cancer cells
How is TERT activation important for the progression of HCC
Most adult cells don’t express telomerase, which maintains telomere length
Cancer cells reactivate TERT, allowing unlimited divisions by keeping their telomere long
TERT activation bypasses the natural limit on cell division, helping tumour cells survive and proliferate indefinitely
How is Cell cycle checkpoint inhibitor inactivation important for the progression of HCC
Proteins like p53, Rb and other cell cycle regulators halt the cell cycle if theres DNA damage
In HCC, these checkpoints are often mutated or inactivated, allowing damaged cells to continue dividing
Without these safeguards, mutations accumulate unchecked, speeding up cancer progression
How do these molecular alterations work together to cause HCC progression
1) Chronic liver injury would cause excessive regeneration which leads to telomere shortening
2) To survive cells would activate TERT
3) Meanwhile, loss of cell cycle control allows mutated cells to escape death
4) This leads to progressive transformation into malignant hepatocytes (HCC)
What are the 3 major mutation clusters in HCC
1) CTNNB1-cluster
2) AXIN1-cluster
3) TP53-cluster
What is the CTNNB1-cluster in HCC and what are its key associated genes
- Involves the mutation of CTNNB1 (Beta-catenin), part of the Wnt/Beta-catenin pathway
Associated genes include:
- TERT (telomere maintenance)
- ARID2 (Chromatin remodelers)
- APOB
- NFE2L2 (Oxidative stress regulator)
- Excludes TP53 and AXIN1 mutations
What is the AXIN1-cluster in HCC and which genes are involved
Involves AXIN1, a negative regulator of the Wnt/β-catenin pathway.
Associated genes include:
- ARID1A (chromatin remodeling)
- RPS6KA3 (MAPK pathway)
Excludes CTNNB1 mutations
What defines the TP53-cluster in HCC and its associated genes?
Involves mutation of TP53, a tumor suppressor gene related to cell cycle control.
Associated genes include:
- CCND1 (Cyclin D1, promotes cell cycle progression)
- KEAP1 (oxidative stress regulation)
- TSC2 (mTOR pathway regulator)
Excludes CTNNB1 mutations
What are the genetic abnormalities that are associated with Steatohepatitis subtype
Frequent IL6/JAK/STAT activation
What are the genetic abnormalities that are associated with Macrotrabecular massive subtype
TP53 mutation and FGF19 amplification
What are the genetic abnormalities that are associated with Fibrolamellar subtype
DNAJB1-PRKACA fusion gene
What is Fibrolamellar Hepatocellular Carcinoma
A rare liver cancer, primarily affects young adults without underlying liver disease, characterized by distinctive fibrous bands under a microscope and a unique DNAJB1-PRKACA fusion protein
It is has a better prognosis
What are the subtypes associated with worse prognosis compared with conventional HCC
- Cirrhotomimetic
- Sarcomatoid carcinoma
- Carcinosarcoma
- Macrotrabecular
- Neutrophil rich
What are the subtypes associated with similar to better prognosis compared with conventional HCC
- Steatohepatitic
- Clear cell
- Chromophobe
- Fibrolamellar
- Lymphocyte rich
What are the subtypes associated with variable to unknown prognosis compared with conventional HCC
- Scirrhous
What is Cholangiocarcinoma
A malignant tumor that arises from the epithelial cells lining the bile ducts. Since bile ducts span inside and outside the liver, cholangiocarcinoma can develop in multiple anatomical locations and is considered an adenocarcinoma
What is intrahepatic Cholangiocarcinoma (iCCA)
- Arises from bile ducts within the liver
- Often presents as a liver mass and can resemble hepatocellular carcinoma radiologically
What is Extrahepatic Cholangiocarcinoma (eCCA)
- Occurs outside the liver, in the bile ducts draining the liver into the duodenum
Further divided into:
- Perihilar
- Distal: closer to the pancreas and duodenum
- More common than intrahepatic
How is Cholangiocarcinoma diagnosed
Diagnosis of exclusion is used because Cholangiocarcinoma can mimic metastases from other adenocarcinomas (e.g., from colon, breast, pancreas)
It is confirmed by exclusion of other primary sites, through imagine, immunohistochemistry and clinical history
Biliary cytology and biopsies as well as markers like:
- CK7
- CK19
- CA19-9
are useful for confirming diagnosis
What is Cirrhosis
A serious, advanced stage of liver disease characterized by permanent scarring and damage to the liver where healthy tissue is replaced by scar tissue, hindering its ability to function properly